Skip to content

News and Articles

Get the latest news and read stories from across the country.

Welcome to our blog, where you can stay up to date with all the latest Pharmacy Alternatives news.

Alzheimer’s: How Does Tau Disrupt Brain Cells?

Scientists have found a previously unknown mechanism in which the protein tau, which is implicated in Alzheimer’s disease, damages brain cells... Read more »

FDA Launches Major Push for New Antimicrobials

The critical need for new medicines to combat infectious diseases that fail to respond to current medical treatment is prompting FDA to... Read more »

FDA Approves New Drug for Treatment of Seizures Associated with Dravet Syndrome

Officials with the FDA approved have approved stiripentol (Diacomit) for the treatment of seizures associated with Dravet syndrome, a rare form... Read more »

Medically Underserved Population Bill

A bill has been created and released that would grant MUP (Medically Underserved Population) status to individuals with intellectual and developmental... Read more »

Smart Inhalers

Inhaled corticosteroids and bronchodilators are the cornerstone treatments for asthma. The first medication helps control inflammation while the second provides immediate... Read more »

Older Adults on PPIs at Higher Risk of Pneumonia, Study Finds

A study in the Journal of the American Geriatrics Society found that long-term use of proton pump inhibitors was associated with... Read more »

New Warning About Benzodiazepine Use and Dementia Risk

Yet another study has linked benzodiazepine use to an increased risk for Alzheimer’s disease (AD). Even though the association between benzodiazepine... Read more »

Analysis of ADHD Drugs: Use Methylphenidate in Kids, Amphetamines in Adults

A meta-analysis of the drugs used to treat attention-deficit/hyperactivity disorder in the short term finds the best choices to be methylphenidate... Read more »

Metabolic Syndrome Risk Greater in Adults Born with Low Birth Weight

Adults born pre-term with very low birth weights may face increased risk for metabolic syndrome, according to findings published in The... Read more »

New Drug Approvals: Aimovig (erenumab-aooe)

Aimovig (erenumab-aooe) is a calcitonin gene-related peptide (CGRP) receptor antagonist, specifically indicated for the preventative treatment of migraine in adults. Aimovig... Read more »